Enhanced solubility and bioavailability of flurbiprofen by cycloamylose

Archives of Pharmacal Research

Volumn 34, Issue 3, 2011, Pages 391-397

  Baek, Hyung Hee ^a   Kwon, So Young ^a   Rho, Shin Joung ^b   Lee, Won Seok ^c   Yang, Ho Joon ^c   Hah, Jung Mi ^d   Choi, Han Gon ^d   Kim, Yong Ro ^b   Yong, Chul Soon ^c  

^a Dankook University   (South Korea)

^b Seoul National University   (South Korea)

^c Yeungnam University   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

Bioavailability; Cycloamylose; Cyclodextrins; Flurbiprofen; Solubility

Indexed keywords

CYCLODEXTRIN; FLUBEN; FLURBIPROFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG SOLUBILITY; MALE; MAXIMUM PLASMA CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; DRUG COMPOUNDING; EXCIPIENTS; FLURBIPROFEN; MALE; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 79959970646     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0306-x     Document Type: Article

References (32)

1. Anderson, B. D. and Conradi, R. A., Predictive Relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J. Pharm. Sci., 74, 815-820 (1985). (Pubitemid 15042168)
2. Choi, H. G., Oh, Y. K., and Kim, C. K., In-situ gelling and mucoadhesive liquid suppository containing acetaminophen : enhanced bioavailability. Int. J. Pharm., 165, 23-32 (1998).
3. Choi, H. G., Lee, B. J., Yong, C. S., Rhee, J. D., Han, J. H., Lee, M. K., Park, K. M., and Kim, C. K., Terfenadine-?-cyclodextrin inclusion complex with the anti-histaminic activity enhancement. Drug Dev. Ind. Pharm., 27, 857-862 (2001). (Pubitemid 33029512)
4. Davies, N. M., Clinical pharmacokinetics of flurbiprofen and its enantiomers. Clin. Pharmacokinet., 28, 100-114 (1995).
5. Del Valle, E. M. M., Cyclodextrins and their uses: a review. Process Biochem., 39, 1033-1046 (2004). (Pubitemid 38527174)
6. Doherty, C. and York, P., Mechanisms of dissolution of furosemide: PVP solid dispersions. Int. J. Pharm., 34, 197-205 (1987). (Pubitemid 17227496)
7. Gessler, K, Usón, I., Takaha, T., Krauss, N., Smith, S. M., Okada, S., Sheldrick, G. M., and Saenger, W., V-Amylose at atomic resolution: X-ray structure of a cycloamylose with 26 glucose residues (cyclomaltohexaicosaose). Proc. Natl. Acad. Sci. U. S. A., 96, 4246-4251 (1999). (Pubitemid 29190321)
8. Gibaldi, M. and Perrier, D., Pharmacokinetics, 2nd ed. Marcel-Dekker, New York, (1982).
9. Gupta, G. D., Jain, S., and Jain, N. K., Formulation of an aqueous injection of flurbiprofen. Pharmazie, 52, 709-712 (1997). (Pubitemid 28066266)
10. Habib, M. J., Phan, M. T., and Owusu-Ababio, G., Dissolution profiles of flurbiprofen in phospholipid solid dispersions. Drug Dev. Ind. Pharm., 24, 1077-1082 (1998). (Pubitemid 28460247)
11. Higuchi, T. and Connors, K. A., Phase-solubility Techniques. Adv. Anal. Chem. Instrument., 117-212 (1965).
12. Kim, C. K. and Yoon, Y. S., Preparation and evaluation of flurbiprofen dry elixir as a novel dosage form using a spray drying technique. Int. J. Pharm., 120, 21-31 (1995).
13. Kitamura, S., Nakatani, K., Takaha, T., and Okada, S., Complex formation of large-ring cyclodextrins with iodine in aqueous solution as revealed by isothermal titration calorimetry. Macromol. Rapid Commun., 20, 612-615 (1999). (Pubitemid 129714767)
14. Lee, S. W., Kim, M. H., and Kim, C. K., Encapsulation of ethanol by spray drying technique: effects of citric acid. Int. J. Pharm., 187, 193-198 (1999).
15. Li, D. X., Oh, Y. K., Lim, S. J., Kim, J. O., Yang, H. J., Sung, J. H., Yong, C. S., and Choi, H. G., Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray drying technique. Int. J. Pharm., 355, 277-284 (2008).
16. Li, D. X., Han, M. J., Prabagar, B., Yan, Y. D., Oh, D. H., Joe, J. H., Seo, Y., Kim, J. O., Park, S. M., Yong, C. S., and Choi, H. G., Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Arch. Pharm. Res., 33, 95-101 (2010).
17. Machida, S., Ogawa, S., Xiaohua, S., Takaha, T., Fujii, K., and Hayashi, K., Cycloamylose as an efficient artificial chaperone for protein refolding. FEBS Lett., 486, 131-135 (2000).
18. Newa, M., Bhandari, K. H., Li, D. X., Kim, J. O., Yoo, D. S., Kim, J. A., Yoo, B. K., Woo, J. S., Lyoo, W. S., Yong, C. S., and Choi, H. G., Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000. Biol. Pharm. Bull., 31, 939-945 (2008). (Pubitemid 351732002)
19. Oh, D. H., Park, Y. J., Yang, H. J., Kim, Y. I., Kang, J. H., Hwang, D. H., Yong, C. S., and Choi, H. G., Physicochemical characterization and in vivo evaluation of flurbiprofenloaded solid dispersion without crystalline change. Drug Deliv., 18, 46-53 (2011).
20. Park, K.-M., Gao, Z.-G., and Kim, C.-K., Assay of flurbiprofen in rat plasma using HPLC with fluorescence detection. J. Liq. Chrom. Relat. Tech., 20, 1849-1855 (1997). (Pubitemid 27305555)
21. Park, K.-M., Lee, M.-K., Hwang, K.-J., and Kim, C.-K., Phospholipid- based microemulsions of flurbiprofen by the spontaneous emulsification process. Int. J. Pharm., 183, 145-154 (1999). (Pubitemid 29257960)
22. Prabagar, B., Yoo, B. K., Woo, J. S., Kim, J. A., Rhee, J. D., Piao, M. G., Yong, C. S., and Choi, H. G., Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with ?-cyclodextrin, Arch. Pharm. Res., 30, 249-254 (2007).
23. Shimada, J., Handa, S., Kaneko, H., and Takada, T., Conformation of novel cycloamylose: Topological aspects and simulations. Macromolecules, 29, 6408-6421 (1996). (Pubitemid 126536609)
24. Society of Toxicology, Guiding Principles in the Use of Animals in Toxicology, (2008): www.toxicology.org/AI/FA/ guidingprinciples.pdf.
25. Szente, L. and Szejtli, J., Cyclodextrins as food ingredients. Trends Food Sci. Technol., 15, 137-142 (2004). (Pubitemid 38300185)
26. Takaha, T. and Smith, S. M., The functions of 4-?-glucanotransferase and their use for the production of cyclic glucans. Biotechnol. Genet. Eng. Rev., 16, 257-280 (1999). (Pubitemid 29386805)
27. Tokumura, T., Muraoka, A., and Machida, Y., Improvement of oral bioavailability of flurbiprofen from flurbiprofen/ beta-cyclodextrin inclusion complex by action of cinnarizine. Eur. J. Pharm. Biopharm., 73, 202-204 (2009).
28. Tomono, K., Mugishima, A., Suzuki, T., Goto, H., Ueda, H., Nagai, T., and Watanabe, J., Interaction between cycloamylose and various drugs. J. Incl. Phenom. Macrocycl. Chem., 44, 267-270 (2002). (Pubitemid 38075704)
29. Uchiyama, H., Tozuka, Y., Imono, M., and Takeuchi, H., Improvement of dissolution and absorption properties of poorly water-soluble drug by preparing spray-dried powders with ?-glucosyl hesperidin. Int. J. Pharm., 392, 101-106 (2010).
30. Yamashita, K., Nakate, T., Okimoto, K., Ohike, A., Tokunaga, Y., Ibuki, R., Higaki, K., and Kimura, T., Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm., 267, 79-91 (2003). (Pubitemid 37352952)
31. Yong, C. S., Yang, C. H., Rhee, J. D., Lee, B. J., Kim, D. C., Kim, D. D., Kim, C. K., Choi, J. S., and Choi, H. G., Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int. J. Pharm., 269, 169-176 (2004). (Pubitemid 38032832)
32. Yong, C. S., Li, D. X., Oh, D. H., Kim, J. A., Yoo, B. K., Woo, J. S., Rhee, J. D., and Choi, H. G., Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde. Arch. Pharm. Res., 29, 431-534 (2005).